
David J. Steadman
Examiner (ID: 6795, Phone: (571)272-0942 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1652 |
| Total Applications | 1737 |
| Issued Applications | 740 |
| Pending Applications | 242 |
| Abandoned Applications | 766 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15740971
[patent_doc_number] => 20200109373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => TRANSGENIC YEAST AND METHOD FOR PRODUCING ETHANOL USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/592181
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16592181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/592181 | Transgenic yeast and method for producing ethanol using the same | Oct 2, 2019 | Issued |
Array
(
[id] => 20402259
[patent_doc_number] => 12492228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => CRM197 protein expression method
[patent_app_type] => utility
[patent_app_number] => 17/638822
[patent_app_country] => US
[patent_app_date] => 2019-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 3144
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638822 | CRM197 protein expression method | Oct 1, 2019 | Issued |
Array
(
[id] => 17719104
[patent_doc_number] => 20220211823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => Clostridial Neurotoxins Comprising an Exogenous Activation Loop
[patent_app_type] => utility
[patent_app_number] => 17/278724
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278724 | Clostridial neurotoxins comprising an exogenous activation loop | Sep 26, 2019 | Issued |
Array
(
[id] => 17236917
[patent_doc_number] => 11180789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Method for bioconversion of mogroside extracts into siamenoside I
[patent_app_type] => utility
[patent_app_number] => 16/584216
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 24
[patent_no_of_words] => 5055
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/584216 | Method for bioconversion of mogroside extracts into siamenoside I | Sep 25, 2019 | Issued |
Array
(
[id] => 15711711
[patent_doc_number] => 20200102621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => METHOD FOR PREPARATION AND SCREENING OF FUNGAL MUTANT WITH HIGH HYDROLYTIC ACTIVITY AND CATABOLITE DEREPRESSED CHARACTER
[patent_app_type] => utility
[patent_app_number] => 16/584785
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/584785 | Method for preparation and screening of fungal mutant with high hydrolytic activity and catabolite derepressed character | Sep 25, 2019 | Issued |
Array
(
[id] => 19281554
[patent_doc_number] => 20240218028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => EXPRESSION AND ENHANCED SECRETION OF ACTIVE MORINGA OLEIFERA COAGULANT PROTEIN IN BACILLUS
[patent_app_type] => utility
[patent_app_number] => 16/582436
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582436 | EXPRESSION AND ENHANCED SECRETION OF ACTIVE MORINGA OLEIFERA COAGULANT PROTEIN IN BACILLUS | Sep 24, 2019 | Abandoned |
Array
(
[id] => 17784904
[patent_doc_number] => 11408017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Composition for producing tagatose and method of producing tagatose using the same
[patent_app_type] => utility
[patent_app_number] => 16/582629
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 9013
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582629 | Composition for producing tagatose and method of producing tagatose using the same | Sep 24, 2019 | Issued |
Array
(
[id] => 17228964
[patent_doc_number] => 20210355520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => METHOD FOR THE PRODUCTION OF AMINO SUGAR CONTAINING PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/276793
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276793 | Method for the production of amino sugar-containing products | Sep 19, 2019 | Issued |
Array
(
[id] => 17937084
[patent_doc_number] => 11471516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => CNS delivery of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 16/573557
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 147
[patent_figures_cnt] => 237
[patent_no_of_words] => 85952
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16573557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/573557 | CNS delivery of therapeutic agents | Sep 16, 2019 | Issued |
Array
(
[id] => 15436081
[patent_doc_number] => 20200032224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => PRODUCTION OF XYLITOL FROM GLUCOSE BY A RECOMBINANT STRAIN
[patent_app_type] => utility
[patent_app_number] => 16/570056
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570056
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/570056 | Production of xylitol from glucose by a recombinant strain | Sep 12, 2019 | Issued |
Array
(
[id] => 15294099
[patent_doc_number] => 20190390185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => POLYPEPTIDES HAVING PROTEASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
[patent_app_type] => utility
[patent_app_number] => 16/565811
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/565811 | POLYPEPTIDES HAVING PROTEASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | Sep 9, 2019 | Abandoned |
Array
(
[id] => 17414374
[patent_doc_number] => 20220049278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHOD FOR PRODUCING ETHANOL FROM LIGNOCELLULOSIC RAW MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/274775
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274775 | Method for producing ethanol from lignocellulosic raw material | Sep 9, 2019 | Issued |
Array
(
[id] => 19738557
[patent_doc_number] => 12215377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => HIV or HCV detection with CRISPR-CAS13A
[patent_app_type] => utility
[patent_app_number] => 17/273752
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 12436
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273752 | HIV or HCV detection with CRISPR-CAS13A | Sep 5, 2019 | Issued |
Array
(
[id] => 17435907
[patent_doc_number] => 11261219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Proteolytic inactivation of select proteins in bacterial extracts for improved expression
[patent_app_type] => utility
[patent_app_number] => 16/562837
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 22940
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/562837 | Proteolytic inactivation of select proteins in bacterial extracts for improved expression | Sep 5, 2019 | Issued |
Array
(
[id] => 17541230
[patent_doc_number] => 11306343
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => 3a-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid
[patent_app_type] => utility
[patent_app_number] => 16/561643
[patent_app_country] => US
[patent_app_date] => 2019-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 25
[patent_no_of_words] => 22469
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16561643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/561643 | 3a-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid | Sep 4, 2019 | Issued |
Array
(
[id] => 16941291
[patent_doc_number] => 11053520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Recombinant
[patent_app_type] => utility
[patent_app_number] => 16/548093
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4296
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/548093 | Recombinant | Aug 21, 2019 | Issued |
Array
(
[id] => 19970683
[patent_doc_number] => 12339286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Metal-reducing enzymatic tag for optical and electron microscopy
[patent_app_type] => utility
[patent_app_number] => 17/266734
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 6154
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266734 | Metal-reducing enzymatic tag for optical and electron microscopy | Aug 8, 2019 | Issued |
Array
(
[id] => 18005305
[patent_doc_number] => 20220364071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/264340
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 202787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -389
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264340 | NOVEL CRISPR ENZYMES AND SYSTEMS | Jul 30, 2019 | Pending |
Array
(
[id] => 15345849
[patent_doc_number] => 20200010816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/525349
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525349 | Genetically engineered | Jul 28, 2019 | Issued |
Array
(
[id] => 17243454
[patent_doc_number] => 20210363197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => cAMP RECEPTOR PROTEIN VARIANT AND METHOD OF PRODUCING L-AMINO ACID USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/956799
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956799 | Camp receptor protein variant and method of producing L-amino acid using the same | Jul 24, 2019 | Issued |